Function Secures $450M Growth Financing From General Catalyst
The preventive-health platform says the backing from General Catalyst’s Customer Value Fund will help it bring lab testing, medical imaging, and personalized health data to millions more people.
Editorial Team · 3 min read
Czech Medtech HTG Medical Wins EU Certification and Passes €1M to Automate ICU Care
The HTG Urogram automates one of the ICU's most mundane hourly tasks — measuring a patient's urine output — and feeds it straight into hospital systems. Now CE-marked and past €1M in funding, the startup is heading for global markets.
Anton Dalsätt · 4 min read
Neko Health Raises $700M Series C Ahead of US Launch
The preventive-scanning company co-founded by Spotify's Daniel Ek has raised one of European health tech's largest-ever rounds — backed by Lightspeed and a long list of high-profile names including Mark Zuckerberg — as it prepares to open in New York.
Editorial Team · 4 min read
Beckham-Backed Supplement Brand IM8 Secures $1 Billion Financing from General Catalyst
Prenetics has landed up to $1 billion to fuel its supplement brand IM8 — but the structure is the story: no equity, no dilution. General Catalyst funds the marketing and takes a capped slice of the revenue it generates.
Editorial Team · 4 min read
Functional-Drinks Brand Reformed Raises $22M Series A to Enter the US
The UK startup turns instant coffee and matcha into functional-wellness products — with collagen, creatine, and mushrooms mixed in. Two years in, it says it's already at ~$70M in annual revenue.
Editorial Team · 3 min read
Anodyne Nanotech Raises $12.6M Series A to Take a Once-Weekly GLP-1 Patch into Human Trials
The Boston biotech wants to replace the GLP-1 injection with a room-temperature patch — no needles, no cold storage. Its Series A funds the first clinical test of that idea.
Editorial Team · 3 min read
A new syndicate, Peers Capital, launches to fund preventive health at the earliest stage
The investor group is backing pre-seed and seed founders across diagnostics, recovery, and longevity through a deal-by-deal model — and they have already closed its first investments
William Ferreira Andrén · 4 min read